Breast Neoplasms: all 12,820 studies

Page 42 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast CancerTerminatedNCT01239745Results posted
• Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast CancerCompletedNCT01237327Phase 3Results posted
• Comparison of Full-Field Digital Mammography With Digital Breast Tomography for Screening Call-Back RatesCompletedNCT01236781Not applicableResults posted
• Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by SurgeryTerminatedNCT01234532Phase 2Results posted
• Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer PatientsCompletedNCT01234402Phase 2Results posted
• Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast CancerCompletedNCT01234337Phase 3Results posted
• Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast CancerCompletedNCT01231659Phase 2Results posted
• Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase InhibitorsTerminatedNCT01225172Phase 2Results posted
• Vitamin D and Breast Cancer Biomarkers in Female PatientsCompletedNCT01224678Phase 3Results posted
• PET/CT Evaluation of Treatment Response in Breast CancerTerminatedNCT01222416Not applicableResults posted
• Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast CancerTerminatedNCT01220128Phase 2Results posted
• RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerTerminatedNCT01217411Phase 1/2Results posted
• Monitoring and Predicting Chemotherapy Response Using DOSICompletedNCT01217385Not applicableResults posted
• Evaluation of the Cook Biodesign® Nipple Reconstruction Cylinder (NRC)CompletedNCT01216319Not applicableResults posted
• A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast CancerCompletedNCT01216176Phase 1/2Results posted
• An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast CancerCompletedNCT01215123Results posted
• A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast CancersCompletedNCT01209195Phase 1Results posted
• Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and ReconstructionCompletedNCT01208974Not applicableResults posted
• Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast CancerTerminatedNCT01207102Phase 2Results posted
• Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerTerminatedNCT01205685Phase 2Results posted
• Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer PatientsCompletedNCT01202591Phase 1/2Results posted
• A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast CancerCompletedNCT01201265Phase 2Results posted
• Predictors of Ovarian Insufficiency in Young Breast Cancer PatientsCompletedNCT01197456Results posted
• Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsActive, not recruitingNCT01196936Phase 2Results posted
• A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast CancerCompletedNCT01196052Phase 2Results posted
• Re-expression of ER in Triple Negative Breast CancersTerminatedNCT01194908Phase 1/2Results posted
• Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast CancerTerminatedNCT01194869Phase 2Results posted
• Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal SymptomsCompletedNCT01194440Phase 2Results posted
• A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast CancerTerminatedNCT01194427Phase 2Results posted
• PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast CancerCompletedNCT01190566Results posted
• An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerTerminatedNCT01187381Results posted
• Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast CancerCompletedNCT01186367Not applicableResults posted
• Trastuzumab and Vinorelbine in Advanced Breast CancerTerminatedNCT01185509Phase 2Results posted
• Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In ChinaCompletedNCT01176916Phase 4Results posted
• Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast CancerTerminatedNCT01167192Phase 2Results posted
• Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin DCompletedNCT01166763Not applicableResults posted
• A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast CancerCompletedNCT01160211Phase 3Results posted
• Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadTerminatedNCT01159067Phase 2Results posted
• Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer PatientsTerminatedNCT01155063Results posted
• Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor TherapyCompletedNCT01153672Not applicableResults posted
• Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast CancerTerminatedNCT01151449Phase 2Results posted
• Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast CancerTerminatedNCT01151215Phase 2Results posted
• Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast CancerCompletedNCT01151046Phase 2Results posted
• Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast CancerCompletedNCT01149083Phase 2Results posted
• QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEACompletedNCT01147965Phase 1/2Results posted
• Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing SurgeryTerminatedNCT01147016Phase 2Results posted
• Effects of Exemestane on Bone StrengthCompletedNCT01144468Results posted
• Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed TherapiesCompletedNCT01142661Not applicableResults posted
• Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast CancerCompletedNCT01142401Phase 2Results posted
• Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBCCompletedNCT01138046Phase 2Results posted
• Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast CancerTerminatedNCT01132664Phase 1/2Results posted
• Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer PatientsCompletedNCT01129336Phase 4Results posted
• RAD001 Plus Carboplatin in Breast Cancer PatientsCompletedNCT01127763Phase 2Results posted
• Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast CancerCompletedNCT01127373Not applicableResults posted
• LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin TreatmentCompletedNCT01125566Phase 3Results posted
• Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerCompletedNCT01124695Phase 2Results posted
• A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast CancerTerminatedNCT01121549Results posted
• A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)CompletedNCT01120184Phase 3Results posted
• GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and BiomarkersTerminatedNCT01118975Phase 1/2Results posted
• Study of Pralatrexate in Female Patients With Previously-treated Breast CancerCompletedNCT01118624Phase 2Results posted
• Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast CancerCompletedNCT01111825Phase 1/2Results posted
• Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone SurgeryCompletedNCT01106898Phase 2Results posted
• Breast and Melanoma Trial With Lymphoseek to Identify Lymph NodesCompletedNCT01106040Phase 3Results posted
• Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast CancerCompletedNCT01105650Phase 2Results posted
• Panobinostat and Letrozole in Treating Patients With Metastatic Breast CancerCompletedNCT01105312Phase 1/2Results posted
• Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)CompletedNCT01104584Phase 3Results posted
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerCompletedNCT01101438Phase 3Results posted
• Neo-Adjuvant Study in Triple Negative Breast Cancer PatientsCompletedNCT01097642Phase 2Results posted
• MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast CancerCompletedNCT01097460Phase 1Results posted
• Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedNCT01095003Phase 3Results posted
• A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast CancerCompletedNCT01094184Phase 4Results posted
• Positron Emission Tomography in Women With Advanced HER2-Positive Breast CancerActive, not recruitingNCT01093612Not applicableResults posted
• Brostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerCompletedNCT01091454Phase 2Results posted
• Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerCompletedNCT01091428Phase 2Results posted
• Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedNCT01091168Phase 3Results posted
• Reducing Pain and Disability After Breast Cancer SurgeryCompletedNCT01089933Not applicableResults posted
• Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01086605Phase 2Results posted
• Demonstrate Efficacy and Safety of Metastatic Breast CancerCompletedNCT01084876Phase 3Results posted
• Evaluate Safety, Efficacy and PharmacokineticsCompletedNCT01084863Phase 1/2Results posted
• Estrogen for Triple Negative Breast CancerTerminatedNCT01083641Phase 2Results posted
• Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving SurgeryCompletedNCT01082211Phase 2Results posted
• Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)TerminatedNCT01077154Phase 3Results posted
• Ixabepilone + Carboplatin Metastatic Breast CancerCompletedNCT01075100Phase 2Results posted
• PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 MutationsCompletedNCT01074970Phase 2Results posted
• Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br caCompletedNCT01074814Early Phase 1Results posted
• Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast CancerCompletedNCT01073865Phase 3Results posted
• Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRICompletedNCT01067976Phase 3Results posted
• Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast CancerCompletedNCT01061359Results posted
• Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST)CompletedNCT01050634Results posted
• Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast CancerCompletedNCT01048099Not applicableResults posted
• Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast CancerCompletedNCT01047358Results posted
• Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer PatientsCompletedNCT01042938Phase 2Results posted
• Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast CancerCompletedNCT01042535Phase 1/2Results posted
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 2Results posted
• Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerCompletedNCT01036087Phase 2Results posted
• RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVFCompletedNCT01035099Phase 4Results posted
• Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01033032Phase 1/2Results posted
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT01031446Phase 1/2Results posted
• Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)TerminatedNCT01029925Phase 2Results posted
• Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated PainCompletedNCT01028352Not applicableResults posted

← Breast Neoplasms overview